Go Pro
NASDAQ:AHCO

AdaptHealth (AHCO) Stock Price, News & Analysis

AdaptHealth logo
$5.81 +0.11 (+1.93%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$5.75 -0.06 (-1.02%)
As of 08/14/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About AdaptHealth Stock (NASDAQ:AHCO)

Advanced

Key Stats

Today's Range
$5.69
$5.91
50-Day Range
$5.22
$11.22
52-Week Range
$5.21
$13.43
Volume
2.35 million shs
Average Volume
3.88 million shs
Market Capitalization
$792.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.29
Consensus Rating
Moderate Buy

Company Overview

AdaptHealth, Inc. operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions. In addition to respiratory therapy, AdaptHealth offers mobility aids like power wheelchairs, walkers and patient lifts, as well as bathroom safety equipment including walk-in tubs, shower chairs and grab bars. These products are supported by in-home setup, training and ongoing clinical monitoring services.

AdaptHealth maintains a nationwide network of patient care centers, serving all 50 states and Puerto Rico through both direct shipments and in-home visits. In October 2022, the company completed the acquisition of Apria Healthcare, further expanding its distribution footprint and service capabilities. AdaptHealth leverages proprietary data analytics and telehealth platforms to track patient adherence and provide remote clinical follow-up.

Founded in 2007 and headquartered in Woburn, Massachusetts, AdaptHealth went public on the Nasdaq under the ticker AHCO in 2014. The company is led by a management team with deep expertise in healthcare operations, regulatory compliance and patient care. AdaptHealth continues to pursue strategic partnerships and acquisitions to broaden its product offerings and strengthen its position in the home healthcare market.

AI Generated. May Contain Errors.

AdaptHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

AHCO MarketRank™: 

AdaptHealth scored higher than 95% of companies evaluated by MarketBeat, and ranked 31st out of 912 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    AdaptHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 7 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    AdaptHealth has a consensus price target of $10.29, representing about 77.0% upside from its current price of $5.81.

  • Amount of Analyst Coverage

    AdaptHealth has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about AdaptHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for AdaptHealth are expected to grow by 140.91% in the coming year, from $0.44 to $1.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AdaptHealth is -3.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AdaptHealth is -3.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    AdaptHealth has a PEG Ratio of 0.30. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    AdaptHealth has a P/B Ratio of 0.57. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about AdaptHealth's valuation and earnings.
  • Percentage of Shares Shorted

    6.05% of the float of AdaptHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    AdaptHealth has a short interest ratio ("days to cover") of 8.19.
  • Change versus previous month

    Short interest in AdaptHealth has recently increased by 0.66%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    AdaptHealth does not currently pay a dividend.

  • Dividend Growth

    AdaptHealth does not have a long track record of dividend growth.

  • News Sentiment

    AdaptHealth has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for AdaptHealth this week, compared to 4 articles on an average week.
  • Search Interest

    14 people have searched for AHCO on MarketBeat in the last 30 days. This is an increase of 1,300% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added AdaptHealth to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $36,504.00 in company stock, which represents 0.0046% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, AdaptHealth insiders have bought 32.18% more of their company's stock than they have sold. Specifically, they have bought $149,930.00 in company stock and sold $113,426.00 in company stock.

  • Percentage Held by Insiders

    1.95% of the stock of AdaptHealth is held by insiders.

  • Percentage Held by Institutions

    82.67% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about AdaptHealth's insider trading history.
Receive AHCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AHCO Stock News Headlines

Gold buyout deals have handed shareholders overnight gains up to 79 percent
Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,228.6% for shareholders of companies like G2 Goldfields, Loncor Gold, and Rupert Resources. Analyst Garrett Goggin, CFA, CMT, tracks which small miners hold the grade, cash flow, and assets that attract buyout interest from major producers. One quarter of his tracked portfolio has already been acquired as the gold bull market's M and A phase accelerates.tc pixel
AdaptHealth (AHCO) Q2 2026 Earnings Call Transcript
See More Headlines

AHCO Stock Analysis - Frequently Asked Questions

AdaptHealth's stock was trading at $9.96 at the start of the year. Since then, AHCO stock has decreased by 41.7% and is now trading at $5.81.

AdaptHealth Corp. (NASDAQ:AHCO) issued its quarterly earnings results on Tuesday, February, 24th. The company reported ($0.76) EPS for the quarter, missing analysts' consensus estimates of $0.34 by $1.10. The business's revenue was down 1.2% on a year-over-year basis.
Read the conference call transcript
.

AdaptHealth's top institutional investors include Reinhart Partners LLC. (5.46%), Moody National Bank Trust Division (0.10%), Paradigm Capital Management Inc. NY (0.09%) and Handelsbanken Fonder AB (0.02%). Insiders that own company stock include Shaw Rietkerk, Albert A Prast, Russell E Schuster III, Kenneth A Samet, Kenneth A Samet and David Solomon Williams III.
View institutional ownership trends
.

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AdaptHealth investors own include Waste Connections (WCN), AUO (AUOTY), American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
2/24/2026
Today
8/16/2026
Next Earnings (Estimated)
11/03/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Distributors
Current Symbol
NASDAQ:AHCO
CIK
1725255
Fax
N/A
Employees
10,900
Year Founded
2012

Price Target and Rating

High Price Target
$13.00
Low Price Target
$8.00
Potential Upside/Downside
+77.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.71)
Trailing P/E Ratio
N/A
Forward P/E Ratio
13.20
P/E Growth
0.3
Net Income
-$70.79 million
Net Margins
-7.07%
Pretax Margin
-7.24%
Return on Equity
3.36%
Return on Assets
1.16%

Debt

Debt-to-Equity Ratio
1.37
Current Ratio
1.12
Quick Ratio
0.98

Sales & Book Value

Annual Sales
$3.24 billion
Price / Sales
0.24
Cash Flow
$4.18 per share
Price / Cash Flow
1.39
Book Value
$10.17 per share
Price / Book
0.57

Miscellaneous

Outstanding Shares
136,340,000
Free Float
133,685,000
Market Cap
$792.14 million
Optionable
Optionable
Beta
1.47

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:AHCO) was last updated on 8/16/2026 by MarketBeat.com Staff.
From Our Partners